Member Exclusive

First-in-class drug may be effective against therapy-resistant breast cancer

University of Texas Southwestern’s Harold C. Simmons Comprehensive Cancer Center (Dallas, TX, USA) researchers have demonstrated that a first-in-class molecule can prevent breast cancer growth in murine and patient-derived models, when traditional therapies stop working.

Go to the profile of Peter Brown
Aug 25, 2017

Please sign in or register for FREE

Register to MedChemNet – the medicinal chemistry network

MedChemNet is a communal space where industry and academic professionals can come together to discuss the latest research and developments, share thoughts and opinions, and build valuable international relationships.


No comments yet. Start the conversation...